MEDCHEMFARMA S.L

Hoja B582515· NIF B10884864

VigenteBarcelona
Registered address :
Activity :
Investigación y desarrollo experimental en biotecnología
Legal form :
Sociedades de responsabilidad limitada
Share capital :
29 189,00 €
Incorporation :
27/07/2022
Director :
Lyhen Gonzalez Lio

Legal information

Legal information for MEDCHEMFARMA S.L

NIF
Hoja registral
IRUS1000382319762
Legal formSociedades de responsabilidad limitada
Share capital29 189,00 €
Incorporation date27/07/2022
Register referenceTomo 48394 · Folio 86 · Hoja B582515
StatusVigente

Activity

MEDCHEMFARMA S.L is a Sociedades de responsabilidad limitada with its registered office in Barcelona, Cataluña. Its declared activity is “Investigación y desarrollo experimental en biotecnología” (CNAE 7211). It was incorporated on 27 July 2022. The Spanish commercial register has published 8 filings for this company, from 27 July 2022 to 7 July 2026, across 4 distinct types of filing. Its registered share capital is 29 189,00 €.

Economic activity (CNAE)

7211 · Investigación y desarrollo experimental en biotecnología

Corporate purpose

INVESTIGACION RELACIONADA CON MODULADORES DE LOS RECEPTORES DE ADENOSINA, MODULADORES DE LOS RECEPTORES PROSTAGLADINA, INHIBIDORES DE HISTONAS DEACETILASAS (HDACS) MODULADORES DE LOS RECEPTORES NUCLEARES DE ANDORGENOS, ETC.

Directors and representatives

Directors

Current

Former

Directors network map

3 nodes Person Company
MEDCHEMFARMA S.LLyhen Gonzalez LioLyhen Gonzalez LioDARPAUFARMA SLDARPAUFARMA SL

Registered actos

  1. Ampliación de capitalPublished 07/07/2026· Registered 30/06/2026· I/A 6
  2. Ampliación de capitalPublished 25/06/2024· Registered 18/06/2024· I/A 5
  3. RevocacionesPublished 02/04/2024· Registered 22/03/2024· I/A 4
  4. NombramientosPublished 02/04/2024· Registered 22/03/2024· I/A 4
  5. Ampliación de capitalPublished 08/05/2023· Registered 26/04/2023· I/A 3
  6. Ampliación de capitalPublished 06/09/2022· Registered 30/08/2022· I/A 2
  7. ConstituciónPublished 27/07/2022· Registered 18/07/2022· I/A 1
  8. NombramientosPublished 27/07/2022· Registered 18/07/2022· I/A 1

Capital · events

  1. 07/07/2026Ampliación de capital
    Resulting capital: 29 189,00 € (+878,00 €)
  2. 25/06/2024Ampliación de capital
    Resulting capital: 28 311,00 € (+3 311,00 €)
  3. 08/05/2023Ampliación de capital
    Resulting capital: 25 000,00 € (+7 946,00 €)
  4. 06/09/2022Ampliación de capital
    Resulting capital: 17 054,00 € (+14 054,00 €)
  5. 27/07/2022Constitución
    Initial capital: 3 000,00 €

Importes obtenidos del BORME cuando se publican (importe de la operación y capital resultante). Algunos anuncios no lo publican; en ese caso consulte el PDF original.

Timeline (BORME)

  1. 07/07/2026#9499639
    Ampliación de capital
    MEDCHEMFARMA S.L. Ampliación de capital. Capital: 878,00 Euros. Resultante Suscrito: 29.189,00 Euros. Ampliación de capital. Capital: 471,00 Euros. Resultante Suscrito: 29.660,00 Euros. Datos registrales. S 8 , H B 582515, I/A 6 (30.06.26).
  2. 25/06/2024#8140129
    Ampliación de capital
    MEDCHEMFARMA S.L. Ampliación de capital. Capital: 3.311,00 Euros. Resultante Suscrito: 28.311,00 Euros. Datos registrales. S 8 , H B 582515, I/A 5 (18.06.24).
  3. 02/04/2024#8013499
    RevocacionesNombramientos
    MEDCHEMFARMA S.L. Revocaciones. ADM.SOLIDAR.: JULIO CESAR CASTRO PALOMINO LARIA;LYHEN GONZALEZ LIO. Nombramientos. ADM.UNICO: LYHEN GONZALEZ LIO. Datos registrales. T 48394 , F 86, S 8, H B 582515, I/A 4 (22.03.24).
  4. 08/05/2023#7515950
    Ampliación de capital
    MEDCHEMFARMA S.L. Ampliación de capital. Capital: 7.946,00 Euros. Resultante Suscrito: 25.000,00 Euros. Datos registrales. T 48394 , F 85, S 8, H B 582515, I/A 3 (26.04.23).
  5. 06/09/2022#7147855
    Ampliación de capital
    MEDCHEMFARMA S.L. Ampliación de capital. Capital: 14.054,00 Euros. Resultante Suscrito: 17.054,00 Euros. Datos registrales. T 48394 , F 85, S 8, H B 582515, I/A 2 (30.08.22).
  6. 27/07/2022#7089972
    ConstituciónNombramientos
    MEDCHEMFARMA S.L. Constitución. Comienzo de operaciones: 1.07.22. Objeto social: INVESTIGACION RELACIONADA CON MODULADORES DE LOS RECEPTORES DE ADENOSINA, MODULADORES DE LOS RECEPTORES PROSTAGLADINA, INHIBIDORES DE HISTONAS DEACETILASAS (HDACS) MODUL

Official documents

Official Registro Mercantil documents that we obtain and deliver to you as PDFs.

Nota informativa mercantil (company extract)

Current registry status: administradores and apoderados with their DNI, objects, capital, registered address and latest accounts filing.

Public

Filed annual accounts

Actual image of the filing for each financial year: balance sheet, profit and loss account and shareholder structure.

Public

Certified articles of association

The company's articles of association in force, certified by the registrador.

Public· Incorporated 2022

Certificate of powers of attorney

Powers in force held by a given apoderado (state their NIF or name).

Public

Certificate of good standing and current officers

Conclusive certificate of existence, good standing and the cargos currently in office.

Public

Certificate of beneficial ownership

The company's official beneficial owners.

Requires a legitimate interest (shareholder, director or obliged entity)

Credit risk report

Commercial credit risk report on the company.

Public

Official documents from Spain's Registro Mercantil · delivered as PDFs. Price set by the official arancel, we send a quote once you request one.

Contact details

WebsitesReserved for registered users
PhoneReserved for registered users
EmailReserved for registered users
Social networks
Full addressPJ ANTONI MACIA I FONOLL NUM.23 ESC.1 P.3 PTA.11 (MATARO), Barcelona
Other linked sitesReserved for registered users
Published addressesReserved for registered users
Opening hoursReserved for registered users

Prospect

Spanish companies in the same line of business — Investigación y desarrollo experimental en biotecnología — are listed together.